M/04/028 – Abbott / Aventis

Page Attachments


Transaction details

proposal whereby Abbott Laboratories and several of its affiliates (“Abbott”) would acquire that part of the business of Aventis S.A. connected with the manufacture, distribution and sale of pharmaceutical products containing either Trandolapril or a combination of Trandolapril/Verapamil as the active ingredient (the “Proposed Transaction”).

Notification date Decision date
Wednesday May 5, 2004 Wednesday, May 19, 2004
Parties Involved Business activities

multinational corporation engaged in the manufacture and supply of a broad range of healthcare products and services.


develops and markets pharmaceutical products.

Economic sector Media merger
Pharmaceuticals No
Submissions from third parties due by:
Phase 1 Phase 2
Current status: Completed
Preliminary investigation (Phase 1)
Authorised Officer Assigned Contact Details


Media enquiries: MKC Communications: 01 7038600

Return to Merger Notifications

Haven’t found what you’re looking for?